Tata 1mg nears Rs 3,000 crore revenue in FY26 as diagnostics-led strategy turns profitable
Five years after Tata Digital acquired a majority stake, Tata 1mg has grown revenue roughly 10X from Rs 309 crore while pursuing disciplined discounting, diagnostics and clinics rather than rapid delivery. Its diagnostics business has crossed Rs 600 crore in annualised revenue.
Tata 1mg reported nearly Rs 3,000 crore FY26 revenue and net profitability after prioritising diagnostics, clinics and disciplined discounting over quick delivery. Its diagnostics unit surpassed Rs 600 crore annualised revenue, contrasting with financially strained e-pharmacy rivals.
Why this matters
The update follows signals that Tata 1mg's FY26 revenue rose to Rs 2,936 crore while combined losses narrowed to Rs 287 crore, and that healthcare losses narrowed as FY26 turnover increased 21%.
The retail-company theme is accelerating, up 224100% QoQ.